| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$88 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 8:21AM |
$0.505 |
$0.375 |
fallen by
25.74%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Mach7 Technologies Limited focuses on strategic investments to enhance product innovation and customer service.
- CARR was reported at A$27.5M as of 30 September 2024.
- The company aims for 15-25% growth in CARR and revenue in FY25.
- Mach7 holds cash reserves of A$21.9M with plans to be cash flow positive in FY25.
- Sales orders for Q1 FY25 amounted to A$2.2M, primarily from ARR-type sales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 8:20AM |
$0.014 |
$0.004 |
fallen by
71.43%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Adherium is on track to onboard over 600 patients by next quarter.
- Strong sales pipeline of over 50 healthcare organizations.
- Pursuing opportunities in new revenue segment – Pharmacy Benefit Management.
- Strategic investment in customer and patient journey process to facilitate continued growth.
- CEO Dr. Paul Mastoridis will depart on 7 January 2025, CEO search now underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$131 |
Phase 3 Protocol Submission to US FDA
|
31 Oct 2024 8:20AM |
$0.200 |
$0.330 |
risen by
65%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Paradigm has submitted the revised Phase 3 (PARA_OA_012) protocol to the FDA.
- The 30-day review period with the FDA starts on October 29, 2024.
- Enrollment for the trial is expected to begin in Q1 2025 at up to 10 Australian sites.
- The submission is a significant milestone for Paradigm in developing a treatment for knee osteoarthritis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tigers Realm Coal Limited (TIG) ORDINARY FULLY PAID |
Materials |
$39 |
2024 September Quarterly Report
|
31 Oct 2024 8:20AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
TIG - Price-sensitive ASX Announcement
Full Release
Key Points
- Tigers Realm Coal Limited is concluding the sale of its Russian subsidiaries.
- A Share Purchase Agreement was signed with APM-Invest for USD 49 million.
- Proceeds are intended to be used for returning capital to shareholders.
- One condition precedent related to presidential approval remains outstanding.
- Revenue from Russian subsidiaries is locked for APM-Invest's benefit.
- Any payments to the Sellers Group may trigger a Material Adverse Event.
- The SPA can be terminated if conditions are not met by October 9, 2024.
- Shareholders will be kept informed of the transaction's progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$5 |
Amended Investor Presentation - IMARC Sydney
|
31 Oct 2024 8:20AM |
$0.090 |
$0.027 |
fallen by
70%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$51 |
Quarterly Activities & Cashflow Report
|
31 Oct 2024 8:20AM |
$0.125 |
$0.205 |
risen by
64%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island signed a binding Letter of Intent with BioCryst for the potential acquisition of antiviral molecule, galidesivir.
- The US FDA approved proposed amendment to the ISLA-101 Phase 2 clinical trial protocol.
- Mr Chris Ntoumenopoulos appointed Non-Executive Director.
- Post quarter, Island commenced its Phase 2a/b PROTECT clinical trial.
- Island secured A$3.5m in new funding.
- Island closed the quarter with a cash position of $0.72 million.
- All subjects have been dosed and exposed to the challenge virus in the Phase 2a trial.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Quickstep Holdings Limited (QHL) ORDINARY FULLY PAID |
Industrials |
- |
Annual Report to shareholders
|
31 Oct 2024 8:20AM |
$0.220 |
$0.575 |
risen by
161.36%
|
|
| Kogan.com Ltd (KGN) ORDINARY FULLY PAID |
Consumer Discretionary |
$395 |
Update - Notification of buy-back - KGN
|
31 Oct 2024 8:20AM |
$4.720 |
$3.980 |
fallen by
15.68%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$88 |
Appendix 4G and Corporate Governance Statement
|
31 Oct 2024 8:20AM |
$0.505 |
$0.375 |
fallen by
25.74%
|
|
| Quickstep Holdings Limited (QHL) ORDINARY FULLY PAID |
Industrials |
- |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2024 8:20AM |
$0.220 |
$0.575 |
risen by
161.36%
|
|
QHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations is $20.8 million, down 14% from FY24.
- EBITDA from continuing operations increased to $2.99 million, a 78% rise year-on-year.
- The Structures business underwent major restructuring to enhance efficiencies and profitability.
- The company is exiting its Services business due to declining orders.
- Net operating cash flows for Q1 were ($4.19 million), impacted by one-off restructuring costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$71 |
Invitation to attend presentation
|
31 Oct 2024 8:19AM |
$0.255 |
$0.280 |
risen by
9.80%
|
|
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,218 |
FY2025 Appendix 4D
|
31 Oct 2024 8:19AM |
$5.890 |
$4.160 |
fallen by
29.37%
|
|
CIA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 19% to C$818,064.
- Net profit attributable to members rose by 23% to C$101,164.
- Dividends declared at C$0.10 per share.
- Net tangible assets per share improved to C$2.78.
- Review of financial statements conducted by Ernst & Young.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitefield Industrials Limited (WHF) ORDINARY FULLY PAID |
Financials |
$700 |
Update - Notification of buy-back - WHFPB
|
31 Oct 2024 8:19AM |
$5.610 |
$5.810 |
risen by
3.57%
|
|
| Bank of Queensland Limited (BOQ) ORDINARY FULLY PAID |
Financials |
$5,159 |
Notice of Annual General Meeting/Proxy Form
|
31 Oct 2024 8:19AM |
$6.500 |
$7.800 |
risen by
20%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$122 |
Daily share buy-back notice - Appendix 3E
|
31 Oct 2024 8:19AM |
$2.100 |
$2.220 |
risen by
5.71%
|
|
| AuMEGA Metals Ltd (AAM) ORDINARY FULLY PAID |
Materials |
$23 |
Disclosure Document - Prospectus Flow Through Placement
|
31 Oct 2024 8:19AM |
$0.056 |
$0.038 |
fallen by
32.14%
|
|
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
$107 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2024 8:19AM |
$0.044 |
$0.094 |
risen by
113.64%
|
|
TMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Trigg acquires 100% of the Achilles Project, containing the Wild Cattle Creek antimony deposit.
- Wild Cattle Creek is Australia's highest-grade undeveloped antimony deposit.
- Trigg aims to restate and expand the WCC resource and has started drilling preparations.
- Exploration at Taylors Arm has identified high-priority targets from satellite imagery.
- Acquisition of Spartan West and Taylors Arm East applications further expands Trigg's footprint.
- Drilling at SW Limey Prospect indicates a new epithermal system discovery.
- Trigg completed a $2.5 million placement to institutional and sophisticated investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fluence Corporation Limited (FLC) ORDINARY FULLY PAID |
Utilities |
$58 |
Fluence Q3 2024 Update Investor Presentation
|
31 Oct 2024 8:19AM |
$0.080 |
$0.053 |
fallen by
33.75%
|
|
FLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Total YTD Q3 2024 Revenue of $30.3M was 28% lower than YTD Q3 2023
- YTD Q3 2024 SPS and Recurring Revenue of $29.1M, representing 13% growth
- YTD Q3 2024 New Orders of $40.5M, highlighted by a 21% increase in certain segments
- Gross margins of 31.8% YTD Q3 2024, an increase of 5.5% over YTD Q3 2023
- Backlog as of Q3 2024 sits at $101.8M, with $70.2M expected to be recognized in the next 12 months
- Revised guidance for FY 2024 to $50-60M of revenue due to project delays
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marmota Limited (MEU) ORDINARY FULLY PAID |
Energy |
$44 |
Quarterly Activities and Cashflow Report
|
31 Oct 2024 8:18AM |
$0.040 |
$0.037 |
fallen by
7.50%
|
|
MEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Marmota achieved over 20,000m of RC drilling in the quarter.
- New high-grade gold extensions discovered at Aurora Tank.
- Goolagong showed significant gold in 11 out of 15 holes drilled.
- First drilling at Campfire Bore completed, with results pending.
- Gold prices reached over A$4,250 per ounce, benefiting exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BHP Group Limited (BHP) ORDINARY FULLY PAID |
Materials |
$202,380 |
Response to Media Speculation regarding Anglo American plc
|
31 Oct 2024 8:18AM |
$43.110 |
$39.870 |
fallen by
7.52%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$41 |
Quarterly Activities Report
|
31 Oct 2024 8:18AM |
$0.052 |
$0.028 |
fallen by
46.15%
|
|
AGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aguia raised A$5.1 million through the placement of approximately 204 million shares.
- The company is listed on the Frankfurt and Stuttgart Stock Exchanges.
- Rehabilitation of the Santa Barbara Gold Project in Colombia is ongoing.
- Negotiations for treatment of phosphate resources in Brazil are continuing.
- A court ruling denied FPPO's request to annul Aguia's license for the Fosfato Três Estradas project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
$3 |
Company Presentation
|
31 Oct 2024 8:18AM |
$0.007 |
$0.002 |
fallen by
78.57%
|
|
| James Bay Minerals Limited (JBY) ORDINARY FULLY PAID |
Materials |
$43 |
Investor Presentation - Resources Rising Stars
|
31 Oct 2024 8:18AM |
$0.620 |
$0.605 |
fallen by
2.42%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$41 |
Appendix 5B Cash Flow Report
|
31 Oct 2024 8:18AM |
$0.052 |
$0.028 |
fallen by
46.15%
|
|
AGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aguia Resources Ltd reported a net cash outflow of $1.93 million from operating activities.
- The company spent $659,000 on exploration and evaluation.
- Capital expenditures for property, plant, and equipment reached $457,000.
- The quarter ended with cash and cash equivalents of $3.61 million.
- The estimated funding available for future operations is approximately 1.87 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aneka Tambang (Persero) Tbk (Pt) (ATM) CHESS DEPOSITARY INTERESTS 1:5 |
Materials |
$2 |
Quarterly Activities Report 3Q24
|
31 Oct 2024 8:18AM |
$0.905 |
$1.155 |
risen by
27.62%
|
|
ATM - Price-sensitive ASX Announcement
Full Release
Key Points
- Eloise produced 3,185 tonnes of copper in concentrate.
- Operating cash flow for the quarter was A$23.8 million.
- Total FY24 production reached a record 13,412 tonnes of copper.
- AISC for the quarter was A$5.67 per pound.
- The Jericho link drive development commenced.
- Exploration drilling returned exceptional results.
- Cash reserves at 30 June 2024 were A$74.3 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
